This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.
- Coronary artery abnormalities
- Innovative biotechnologies
- Intravenous immunoglobulin
- Kawasaki disease
- Personalized medicine
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health